FREE ANDROGEN INDEX (FAI)

FREE ANDROGEN INDEX (FAI) is a specialized diagnostic biochemical test designed to calculate the ratio of testosterone to sex hormone-binding globulin (SHBG). The FAI provides an accurate estimation of biologically active, free testosterone levels in the blood, helping clinicians evaluate conditions related to hyperandrogenism, polycystic ovary syndrome (PCOS), hirsutism, and hypogonadism.

Measurement of hormonal indices provides direct clinical insight into endocrine and reproductive health. Because early identification of hormonal imbalances supports timely dietary, lifestyle, and medical intervention, specialized biochemical testing supplies essential clinical data for endocrinology, gynecology, internal medicine, and reproductive health evaluations.

The test requires a blood specimen collected by a qualified person using standard containers, followed by precise analysis using automated laboratory immunoassay techniques. Results must always be interpreted in conjunction with the patient's clinical presentation, menstrual history, and comprehensive hormone panels.

Benefits of FREE ANDROGEN INDEX (FAI) Testing

• Provides a reliable estimation of active, free testosterone levels.
• Helps diagnose polycystic ovary syndrome (PCOS) and hyperandrogenism.
• Assists clinicians in endocrinology and gynecological evaluations.
• Aids in assessing symptoms such as unexplained hair growth, acne, or hair loss.
• Supports tracking of specialized hormonal and metabolic care plans.
• Complements total testosterone, SHBG, and LH/FSH hormone panels.
• Utilizes precise laboratory immunoassay techniques for reliable results.
• Assists specialists in determining appropriate medical and hormonal management strategies.
• Provides dependable turnaround times to support specialized clinical care.
• Utilizes standard venous blood collection procedures.

Clinical Indications and Applications

Hormone Screening: The primary clinical indication is evaluating patients presenting with symptoms of hyperandrogenism, irregular menstrual cycles, PCOS, or unexplained endocrine imbalances.

Clinical Assessment: The test is utilized when screening for bioavailable testosterone abnormalities in specialized clinical settings.

Why Doctors Recommend This Test

Endocrinologists, gynecologists, internal medicine specialists, and physicians recommend this test when investigating hormonal irregularities or managing reproductive health. It delivers essential quantitative data required to guide safe clinical intervention.

Following proper blood collection guidelines will ensure a smooth and efficient testing procedure.

What Happens During The Procedure?

The collection procedure involves obtaining a blood specimen drawn from a vein by a qualified phlebotomist using a clean, standard collection container provided by the healthcare facility under appropriate supervision protocols.

Once obtained, the sample is tested in the laboratory using advanced immunoassay analyzers to quantify testosterone and SHBG levels for FAI calculation. The procedure takes only a few minutes.

Normal Reporting Time

The report for the FREE ANDROGEN INDEX (FAI) test is generally available within 24 to 48 hours due to standard laboratory processing times. Results must be reviewed promptly with the referring physician or specialist.

Who Should Consider This Test?

• Women evaluated for polycystic ovary syndrome (PCOS), irregular periods, or excess hair growth.
• Individuals investigated for hormonal imbalances or androgen status as directed by a clinician.

Understanding Test Results

Test results provide a calculated index value evaluated against established laboratory reference ranges for gender and age.

Elevated Findings: High FAI values indicate an excess of free, active androgens, commonly associated with conditions like PCOS or hyperandrogenism.

Low Findings: Low FAI values may suggest reduced androgen activity or other endocrine considerations.

Clinical Limitations

The Free Androgen Index is a calculated ratio and must be interpreted alongside clinical symptoms and full endocrine panels.

Important Safety Information

Severe hormonal symptoms or acute medical conditions require immediate medical attention. Patients must consult their healthcare provider or specialist to interpret endocrine screening findings.